Evidence library
Verified study rows retain their model or population, endpoint, evidence tier, review date, and direct source.
Findings by compound
- 01RetatrutidePhase 1–24 verified studiesThe trial reported a −24.2% least-squares mean body-weight change in one study arm. ↗338 adults with obesity, or overweight plus a weight-related condition, without diabetesJastreboff et al., NEJM 2023Phase 1–2
- 02TirzepatidePhase 32 verified studiesThe trial reported a −20.9% mean body-weight change in one study arm. ↗2,539 adults with obesity, or overweight plus a complication, excluding diabetesJastreboff et al., NEJM 2022Phase 3
- 04TB-500In vitro1 verified studyThe full-length thymosin beta-4 study reported endothelial migration and angiogenesis findings; the study does not establish those findings for the TB-500 fragment. ↗Human umbilical-vein endothelial cells and migration assaysMalinda, Goldstein & Kleinman, FASEB Journal 1997In vitro
- 07TesamorelinPhase 32 verified studiesThe trial reported a −15.2% CT visceral-adipose-tissue change compared with +5.0% for placebo. ↗412 HIV-positive adults with abdominal-fat accumulationFalutz et al., NEJM 2007Phase 3
- 08IGF-1 LR3In vitro1 verified studyThe cell-culture study reported proliferative stimulation in that conditioned-medium model. ↗Cultured postnatal rat lung fibroblastsPrice, Experimental Lung Research 2004In vitro
- 09MOTS-cAnimal1 verified studyThe study reported folate-cycle and AMPK findings alongside mouse metabolic observations. ↗Murine skeletal muscle, myotubes, and mouse diet/age modelsLee et al., Cell Metabolism 2015Animal
- 105-Amino-1MQAnimal1 verified studyThe study reported increased NAD+ and SAM in adipocytes and reduced adiposity in diet-induced-obese mice. ↗Differentiated adipocytes and diet-induced-obese miceNeelakantan et al., Biochemical Pharmacology 2018Animal